In my earlier post I was trying to be condescending. I don't really think it'll take 10 years to get to market.
If our drug works the way it is expected, and I think it will, it will have such a good efficacy and safety profile that we will qualify for one of the fda quicker routes to market. But we don't have to think that far ahead. If our drug works it will become instantly hugely valued imho. Maybe not by the average asx investor, but by the global large pharmas. This news could be anytime within the next 12 months.
Regarding the market cap, here's a chart taken from somewhere else. Note again how low imu would be at around $80m. ok, some of these stocks have more advanced programs, but none have such a big realistic upside as imu. I still think a $300m mkt cap is reasonable.
Add to My Watchlist
What is My Watchlist?
